Ixabepilone and Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Ossium Health, Inc.
St. Jude Children's Research Hospital
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Umoja Biopharma
University Hospital, Strasbourg, France
City of Hope Medical Center
M.D. Anderson Cancer Center
Nanjing IASO Biotechnology Co., Ltd.
Massachusetts General Hospital
Institut Bergonié
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
M.D. Anderson Cancer Center
Emory University
OHSU Knight Cancer Institute
University of Kansas Medical Center
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
H. Lee Moffitt Cancer Center and Research Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Emory University
Mayo Clinic
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
The Hospital for Sick Children
Abramson Cancer Center at Penn Medicine
University of Chicago
University of Chicago
Mayo Clinic
City of Hope Medical Center
Stanford University
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
University of California, San Francisco
Massachusetts General Hospital
EMD Serono
Dana-Farber Cancer Institute
Yale University
Mayo Clinic
University of Southern California
Washington University School of Medicine
Eastern Hepatobiliary Surgery Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center